vs

Side-by-side financial comparison of BREAD FINANCIAL HOLDINGS, INC. (BFH) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $975.0M, roughly 1.3× BREAD FINANCIAL HOLDINGS, INC.). On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 5.4%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -0.8%).

Bread Financial Holdings, Inc. is an American publicly traded provider of private label credit cards, coalition loyalty programs, and direct marketing, derived from the capture and analysis of transaction-rich data.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

BFH vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.3× larger
DXCM
$1.3B
$975.0M
BFH
Growing faster (revenue YoY)
DXCM
DXCM
+16.2% gap
DXCM
21.6%
5.4%
BFH
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-0.8%
BFH

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BFH
BFH
DXCM
DXCM
Revenue
$975.0M
$1.3B
Net Profit
$267.3M
Gross Margin
62.9%
Operating Margin
4.9%
25.6%
Net Margin
21.2%
Revenue YoY
5.4%
21.6%
Net Profit YoY
153.6%
EPS (diluted)
$1.21
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFH
BFH
DXCM
DXCM
Q1 26
$1.3B
Q4 25
$975.0M
$1.3B
Q3 25
$971.0M
$1.2B
Q2 25
$929.0M
$1.2B
Q1 25
$970.0M
$1.0B
Q4 24
$925.0M
$1.1B
Q3 24
$983.0M
$994.2M
Q2 24
$939.0M
$1.0B
Net Profit
BFH
BFH
DXCM
DXCM
Q1 26
$267.3M
Q4 25
$267.3M
Q3 25
$188.0M
$283.8M
Q2 25
$139.0M
$179.8M
Q1 25
$138.0M
$105.4M
Q4 24
$151.7M
Q3 24
$2.0M
$134.6M
Q2 24
$133.0M
$143.5M
Gross Margin
BFH
BFH
DXCM
DXCM
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
BFH
BFH
DXCM
DXCM
Q1 26
25.6%
Q4 25
4.9%
25.6%
Q3 25
20.2%
20.1%
Q2 25
18.7%
18.4%
Q1 25
20.3%
12.9%
Q4 24
-2.9%
17.0%
Q3 24
4.1%
15.3%
Q2 24
19.2%
15.7%
Net Margin
BFH
BFH
DXCM
DXCM
Q1 26
21.2%
Q4 25
21.2%
Q3 25
19.4%
23.5%
Q2 25
15.0%
15.5%
Q1 25
14.2%
10.2%
Q4 24
13.6%
Q3 24
0.2%
13.5%
Q2 24
14.2%
14.3%
EPS (diluted)
BFH
BFH
DXCM
DXCM
Q1 26
$0.67
Q4 25
$1.21
$0.67
Q3 25
$3.96
$0.70
Q2 25
$2.94
$0.45
Q1 25
$2.78
$0.27
Q4 24
$0.08
$0.37
Q3 24
$0.05
$0.34
Q2 24
$2.66
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFH
BFH
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$3.6B
$917.7M
Total DebtLower is stronger
$4.3B
Stockholders' EquityBook value
$3.3B
$2.7B
Total Assets
$22.7B
$6.3B
Debt / EquityLower = less leverage
1.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFH
BFH
DXCM
DXCM
Q1 26
$917.7M
Q4 25
$3.6B
$917.7M
Q3 25
$3.8B
$1.8B
Q2 25
$3.8B
$1.2B
Q1 25
$4.2B
$904.9M
Q4 24
$4.0B
$606.1M
Q3 24
$3.5B
$621.2M
Q2 24
$4.1B
$939.2M
Total Debt
BFH
BFH
DXCM
DXCM
Q1 26
Q4 25
$4.3B
Q3 25
$3.8B
Q2 25
$4.2B
Q1 25
$5.1B
Q4 24
$5.6B
Q3 24
$4.6B
Q2 24
Stockholders' Equity
BFH
BFH
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$3.3B
$2.7B
Q3 25
$3.3B
$2.7B
Q2 25
$3.2B
$2.6B
Q1 25
$3.1B
$2.3B
Q4 24
$3.1B
$2.1B
Q3 24
$3.1B
$2.0B
Q2 24
$3.2B
$2.4B
Total Assets
BFH
BFH
DXCM
DXCM
Q1 26
$6.3B
Q4 25
$22.7B
$6.3B
Q3 25
$21.7B
$7.5B
Q2 25
$21.8B
$7.3B
Q1 25
$22.4B
$6.8B
Q4 24
$22.9B
$6.5B
Q3 24
$21.7B
$6.4B
Q2 24
$22.1B
$6.8B
Debt / Equity
BFH
BFH
DXCM
DXCM
Q1 26
Q4 25
1.29×
Q3 25
1.14×
Q2 25
1.34×
Q1 25
1.67×
Q4 24
1.82×
Q3 24
1.47×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFH
BFH
DXCM
DXCM
Operating Cash FlowLast quarter
$568.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFH
BFH
DXCM
DXCM
Q1 26
Q4 25
$568.0M
$294.0M
Q3 25
$605.0M
$659.9M
Q2 25
$526.0M
$303.0M
Q1 25
$393.0M
$183.8M
Q4 24
$479.0M
$301.4M
Q3 24
$456.0M
$199.5M
Q2 24
$477.0M
$279.4M
Free Cash Flow
BFH
BFH
DXCM
DXCM
Q1 26
Q4 25
$192.1M
Q3 25
$579.4M
Q2 25
$208.9M
Q1 25
$96.8M
Q4 24
$176.8M
Q3 24
$88.3M
Q2 24
$213.3M
FCF Margin
BFH
BFH
DXCM
DXCM
Q1 26
Q4 25
15.3%
Q3 25
47.9%
Q2 25
18.1%
Q1 25
9.3%
Q4 24
15.9%
Q3 24
8.9%
Q2 24
21.2%
Capex Intensity
BFH
BFH
DXCM
DXCM
Q1 26
Q4 25
8.1%
Q3 25
6.7%
Q2 25
8.1%
Q1 25
8.4%
Q4 24
11.2%
Q3 24
11.2%
Q2 24
6.6%
Cash Conversion
BFH
BFH
DXCM
DXCM
Q1 26
Q4 25
1.10×
Q3 25
3.22×
2.33×
Q2 25
3.78×
1.69×
Q1 25
2.85×
1.74×
Q4 24
1.99×
Q3 24
228.00×
1.48×
Q2 24
3.59×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons